Clinical Trial Update: Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial update on hydroxychloroquine for COVID-19 shows efficacy and safety data from completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: Pneumonia, Pneumocystis, Coronavirus | Phase 3 | Status: COMPLETED